Multicentre randomised phase III trial comparing pembrolizumab versus standard chemotherapy for advanced pre-treated malignant pleural mesothelioma.
Coordinador en España: Dr. Ernest Nadal
- Institut Català d’Oncologia-Hospitalet
- Hospital Clínico Universitario de Valladolid
- Hospital Teresa Herrera, A Coruña